regal must have spent significant time and effort($) behind the...

regal must have spent significant time and effort($) behind the scenes to do their own due diligence and obviously DFA lenders did probably even more DD - the real reason for OPT ph3 failure will come out in time - and it is not because eylea/lucentis has suddenly became 70% more effective after 15 years in the market. Bad trial design and bad execution is probably the most obvious reasons. sozinibercept clearly works as per phase 2b data which has been peer reviewed in many medical journals.